Evidence map›Paper›PMID 41953390›Full record

ArticleJHLT open2026

Outcomes of microaxial flow pump use in acute-on-chronic heart failure.

W H Te Gussinklo, T Azami, G Romano, M Eden, P Schlegel, J Kremer, R Arif, M Karck, A L Meyer

Abstract read
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

W H Te GussinkloDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
T AzamiDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
G RomanoDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
M EdenDepartment of Cardiology, University Hospital Heidelberg, Heidelberg, Germany.
P SchlegelDepartment of Cardiology, University Hospital Heidelberg, Heidelberg, Germany.
J KremerDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
R ArifDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
M KarckDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
A L MeyerDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The mortality rate associated with acute decompensated heart failure (ADHF) is high, and prognosis depends on restoring cardiac output. Patients frequently require mechanical circulatory support (MCS). The Impella microaxial flow pump (mAFP) is a short-term MCS used to stabilize patients. We report outcomes of mAFP use in patients with pre-existing chronic heart failure who presented with ADHF. Materials and Methods: This retrospective single-center study included all patients with a history of chronic heart failure who presented with ADHF and were managed with mAFP. Demographic characteristics, hemodynamic variables, complications, and clinical outcomes were evaluated. Results: Fifty-eight patients were included. Patients were managed with the Impella 5.5/5.0 ( Conclusion: The mAFP demonstrates favorable outcomes in patients with chronic heart failure who present with ADHF. It resulted in significant improvements in hemodynamic parameters, and most patients survived to durable LVAD or transplantation. In this heterogenous patient group, only a few survived definitive weaning from mAFP.

Indexed as

Acute heart failureChronic heart failureMechanical circulatory supportMicroaxial flow pumpTemporary ventricular assist device

Identifiers

PMID41953390
PMCPMC13053999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.